Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2010-8-25
pubmed:abstractText
The term tumor budding has been applied to single cells or small clusters of up to four cells within the stromal tissue at the invasive margin of colorectal cancers. This morphologic feature is increasingly being recognized as an adverse prognostic factor. The purpose of this study was to evaluate the clinicopathologic significance of tumor budding in adenocarcinomas of the lung.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1556-1380
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
5
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1361-8
pubmed:meshHeading
pubmed-meshheading:20631633-Adenocarcinoma, pubmed-meshheading:20631633-Adenocarcinoma, Bronchiolo-Alveolar, pubmed-meshheading:20631633-Cadherins, pubmed-meshheading:20631633-Carcinoma, Papillary, pubmed-meshheading:20631633-Cell Adhesion Molecules, pubmed-meshheading:20631633-Follow-Up Studies, pubmed-meshheading:20631633-Humans, pubmed-meshheading:20631633-Immunoenzyme Techniques, pubmed-meshheading:20631633-Lung Neoplasms, pubmed-meshheading:20631633-Lymphatic Metastasis, pubmed-meshheading:20631633-Neoplasm Invasiveness, pubmed-meshheading:20631633-Neoplasm Staging, pubmed-meshheading:20631633-Pleural Neoplasms, pubmed-meshheading:20631633-Prognosis, pubmed-meshheading:20631633-Survival Rate, pubmed-meshheading:20631633-Tissue Array Analysis, pubmed-meshheading:20631633-Tumor Markers, Biological, pubmed-meshheading:20631633-beta Catenin
pubmed:year
2010
pubmed:articleTitle
Histopathologic features of the tumor budding in adenocarcinoma of the lung: tumor budding as an index to predict the potential aggressiveness.
pubmed:affiliation
Pathology Division, Research Center for Innovative Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't